| 2009 |
RNF168 is a chromatin-associated RING finger E3 ubiquitin ligase that binds ubiquitin via MIU domains, assembles at DSBs in an RNF8-dependent manner, and amplifies K63-linked ubiquitin conjugates on H2A and H2AX to levels required for retention of 53BP1 and BRCA1 at damage sites. |
Co-IP, ubiquitin-binding assays, RNAi knockdown, immunofluorescence at DSB foci, in vivo and in vitro ubiquitylation assays |
Cell |
High |
19203579
|
| 2009 |
RNF168 contains two MIU (motif interacting with ubiquitin) domains whose inactivation impairs ubiquitin binding in vitro and reduces chromatin association in vivo; RNF168 ubiquitylates H2A and H2AX (but not H2B) forming K63-linked polyubiquitin chains in vitro and in vivo. |
In vitro ubiquitin-binding assay, in vitro/in vivo ubiquitylation assay, mutagenesis of MIU domains, immunofluorescence |
BMC molecular biology |
High |
19500350
|
| 2012 |
RNF168 (not RNF8) catalyzes monoubiquitination of nucleosomal H2A/H2AX specifically at K13-15; RNF8 is inactive toward nucleosomal H2A. A charged residue in the RNF168 RING domain determines nucleosomal substrate recognition. K63-linked ubiquitin chains are conjugated on top of RNF168-dependent K13-15 monoubiquitination, not K118-119. |
In vitro nucleosomal ubiquitylation assay, structure-based mutagenesis of RING domains, mass spectrometry to map ubiquitylation sites |
Cell |
High |
22980979
|
| 2012 |
RNF168 ubiquitylates JMJD2A/KDM4A, targeting it for proteasomal degradation; this removes a competitor of 53BP1 for dimethylated H4K20, thereby allowing 53BP1 recruitment to DNA damage sites. |
In vivo ubiquitylation assay, co-IP, RNAi knockdown epistasis, immunofluorescence at DSB foci |
The EMBO journal |
Medium |
22373579
|
| 2012 |
RNF168 ubiquitylates histone H2A at a novel N-terminal 'bidentate' site comprising K13 and K15; inactivating both N-terminal (K13/K15) and C-terminal (K118/K119) sites is required to fully abolish damage-induced ubiquitination, indicating these are unique, non-redundant acceptors. |
Mutagenesis of histone lysine residues, in vivo ubiquitylation assay, immunofluorescence |
Cell cycle |
High |
22713238
|
| 2012 |
SMARCA5/SNF2H is recruited to DSBs in a PARP1-dependent manner, interacts with RNF168 in a DNA damage- and PARP-dependent manner, and promotes RNF168 accumulation at DSBs; RNF168 itself becomes poly(ADP-ribosyl)ated after DNA damage. |
Co-IP, immunofluorescence, RNAi knockdown, laser micro-irradiation |
Journal of cell science |
Medium |
23264744
|
| 2013 |
RNF168 mediates K63-linked ubiquitylation of 53BP1, which is required for the initial recruitment of 53BP1 to DSBs and for its functions in DNA repair and checkpoint activation. |
In vivo ubiquitylation assay, Co-IP, K63-specific ubiquitin mutants, immunofluorescence, checkpoint assays |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
24324146
|
| 2013 |
USP44 counteracts RNF8/RNF168-mediated ubiquitylation of H2A and is specifically recruited to RNF168-generated ubiquitylation products at DSBs, acting as a negative regulator at the level of RNF168 accrual. |
DUB overexpression screen, H2A deubiquitylation assay, immunofluorescence, RNAi |
The Journal of biological chemistry |
Medium |
23615962
|
| 2013 |
USP3 removes ubiquitin at K13 and K15 of H2A/γH2AX (RNF168 target sites) as well as K118/K119 of H2AX in response to DNA damage, counteracting RNF168-mediated ubiquitination. |
In vitro deubiquitylation assay, co-IP, immunofluorescence, ectopic expression experiments |
Cell cycle |
Medium |
24196443
|
| 2013 |
RNF168 forms a functional complex with RAD6A/RAD6B E2 enzymes; this RNF168-RAD6 complex ubiquitinates histone H1.2 in vitro and regulates DNA damage-induced H1.2 ubiquitination in vivo. |
E2 RNAi screen, Co-IP, in vitro ubiquitylation assay, immunofluorescence |
Journal of cell science |
Medium |
23525009
|
| 2014 |
The nucleosome acidic patch is required for RNF168-dependent H2A/H2AX ubiquitination at K13/15 both in vitro and in vivo; H2A/H2B dimers and nucleosomes actively stimulate E3-mediated discharge of ubiquitin from E2, redirecting the reaction toward the target lysines. |
In vitro ubiquitylation assay with acidic-patch mutant nucleosomes, viral LANA peptide perturbation in vivo, fluorescence-based E2~Ub discharge assay |
Nature communications |
High |
24518117
|
| 2014 |
The nucleosome acidic patch is required for both RNF168-dependent H2AX ubiquitination and DDR factor (53BP1, BRCA1) recruitment in vivo; perturbation of the acidic patch by the LANA viral peptide phenocopies RNF168 loss. |
In vitro ubiquitylation assay, viral LANA peptide expression, RNAi, immunofluorescence |
PLoS genetics |
Medium |
24603765
|
| 2014 |
RNF168 contains a novel UBD designated UMI (UIM- and MIU-related UBD); the UMI binds ubiquitin via two leucine residues and is required together with MIU domains for proper RNF168 localization and H2A ubiquitination. |
Mutagenesis, ubiquitin-binding assays, immunofluorescence, in vivo ubiquitylation assay |
Molecular and cellular biology |
Medium |
21041483
|
| 2014 |
RNF168 mediates NEDD8 conjugation (neddylation) to H2A and is itself neddylated; neddylation of RNF168 is required for its interaction with E2 enzyme Ubc13 and its ubiquitin ligase activity. H2A neddylation antagonizes H2A ubiquitylation. |
In vivo neddylation assay, Co-IP, mutagenesis, immunofluorescence |
Journal of cell science |
Medium |
24634510
|
| 2014 |
RNF168 interacts with and ubiquitylates topoisomerase IIα (TOP2α), regulating its decatenation activity and chromatin association; USP10 counteracts this by deubiquitylating TOP2α. |
Co-IP, in vivo ubiquitylation assay, decatenation assay, RNAi |
Nature communications |
Medium |
27558965
|
| 2015 |
RNF168 promotes K27-linked (noncanonical) ubiquitin chain formation both in vitro and in vivo; K27-ubiquitin on chromatin is the major ubiquitin mark upon DNA damage and is directly recognized by 53BP1, Rap80, RNF168, and RNF169. |
In vitro ubiquitylation assay with K27R ubiquitin mutants, mass spectrometry chain-linkage analysis, immunofluorescence with ubiquitin mutants in cells |
Cell reports |
Medium |
25578731
|
| 2015 |
USP7 deubiquitinase physically binds RNF168, stabilizes it against DNA damage-induced degradation, and its deubiquitylase activity toward RNF168 is required to maintain H2A ubiquitination and downstream BRCA1/53BP1 foci formation. |
Co-IP (in vitro and in vivo), in vivo ubiquitylation assay, overexpression rescue experiments, RNAi |
Cell cycle |
Medium |
25894431
|
| 2015 |
LSD1 is recruited to DSBs in an RNF168-dependent manner and interacts directly with RNF168 and 53BP1; RNF168-dependent 53BP1 ubiquitination requires CK2-mediated phosphorylation of LSD1 at S131/S137, which promotes LSD1-RNF168 interaction. |
Co-IP, immunofluorescence, phosphorylation assay (CK2/WIP1), mutagenesis |
Nucleic acids research |
Medium |
25999347
|
| 2015 |
RNF168 partially localizes to PML nuclear bodies via its UMI/MIU1 ubiquitin-interacting region; RNF168 binds hybrid SUMO2-K63 ubiquitin chains preferentially over K63-ubiquitin chains alone (confirmed in vitro); RNF168 overexpression increases ubiquitylation and SUMO2 modification of PML. |
shRNA screen, in vitro ubiquitin/SUMO chain binding assay, Co-IP, immunofluorescence |
Journal of cell science |
Medium |
26675234
|
| 2016 |
RNF168 interacts with FOXM1 and mediates its K48-linked polyubiquitination and proteasomal degradation in response to epirubicin; SUMOylation of FOXM1 is required for RNF168 recruitment to FOXM1; RNF8 recruits RNF168 to this substrate. |
Co-IP, in vivo ubiquitylation assay, cycloheximide chase, SUMO-defective mutant analysis, gene promoter-reporter assay |
Oncogenesis |
Medium |
27526106
|
| 2017 |
RNF168 directly interacts with PALB2 via a newly identified PALB2-interacting domain (PID) in RNF168 and the WD40 domain in PALB2; this interaction links H2A ubiquitylation to PALB2-dependent homologous recombination at DSBs in S/G2 cells. |
Co-IP, pull-down, mutagenesis of PID domain, HR assay, immunofluorescence |
eLife |
High |
28240985
|
| 2017 |
RNF169 (RNF168 paralog) binds ubiquitylated H2A-K13/15 on the nucleosome via a three-pronged mechanism involving a canonical ubiquitin-binding helix and two arginine-rich motifs contacting the nucleosome acidic patch; this high-affinity binding displaces 53BP1 from ubiquitylated chromatin. |
Methyl-TROSY NMR, molecular dynamics simulations, cryo-EM validation, biochemical binding assays |
eLife |
High |
28406400
|
| 2017 |
53BP1 binds RNF168-mediated mono-ubiquitylated H2A-K15 in NCP dimethylated at H4K20; RNF169 stabilizes a pre-existing ubiquitin orientation on the nucleosome via a conformational selection mechanism to outcompete 53BP1; RAD18 binds tightly to ubiquitylated NCP through a domain contacting both ubiquitin and nucleosome surfaces accessed by 53BP1. |
NMR spectroscopy, biochemical binding assays, mutagenesis |
Molecular cell |
High |
28506460
|
| 2017 |
HUWE1-mediated histone H1 ubiquitylation at multiple lysines is required upstream for RNF168 recruitment and 53BP1 assembly at DSBs; HUWE1 depletion reduces RNF168 foci without affecting MDC1 (upstream of H1 ubiquitylation). |
Quantitative di-Gly proteomics, RNAi, immunofluorescence at DSB foci |
Scientific reports |
Medium |
29127375
|
| 2018 |
mTORC1-S6K1 phosphorylates RNF168 at Ser60, inhibiting its E3 ligase activity and accelerating its proteasomal degradation; a phospho-deficient S60A mutant rescues DNA damage repair defects caused by LKB1 loss. |
In vitro kinase assay, phospho-specific antibody, co-IP, proteasome assay, mutagenesis, mouse tumor model |
Nature cell biology |
High |
29403037
|
| 2018 |
L3MBTL2 is ubiquitylated by RNF8 and the resulting ubiquitylated L3MBTL2 directly recruits RNF168 to DNA damage sites, providing the mechanistic link between RNF8 and RNF168 in sequential DSB signaling. |
Co-IP, in vivo ubiquitylation assay, immunofluorescence, RNAi epistasis |
Nature cell biology |
High |
29581593
|
| 2018 |
Crystal structures of RNF168 UDM1 and UDM2 bound to K63-linked diubiquitin reveal that both modules fold as single α-helices that simultaneously contact distal and proximal ubiquitin moieties, conferring K63-chain specificity; UDM2 interaction with ubiquitylated targets primarily drives RNF168 recruitment to DSBs. |
X-ray crystallography, biochemical binding assays, mutagenesis, immunofluorescence in U2OS cells |
Nature communications |
High |
29330428
|
| 2018 |
RNF168 ubiquitinates PARP1 via K48-linked chains on multiple lysines, accelerating PARP1 degradation in the presence of PAR chains; PAR-binding by RNF168 is required for this activity and for regulating HR/NHEJ balance. |
Mass spectrometry (ubiquitination site mapping), in vivo ubiquitylation assay, Co-IP, comet assay, HR/NHEJ reporter assays |
Molecules and cells |
Medium |
30037213
|
| 2018 |
RNF126 directly interacts with RNF168 and ubiquitinates it; RNF126 overexpression diminishes H2AX ubiquitination and downstream 53BP1/RAP80 foci in a catalytic activity-dependent manner, negatively regulating RNF168 function. |
Co-IP, in vivo ubiquitylation assay, immunofluorescence, HR reporter assay, catalytic mutant analysis |
Genomics, proteomics & bioinformatics |
Medium |
30529286
|
| 2019 |
RNF168 directly ubiquitylates DHX9 helicase to facilitate its recruitment to R-loop-prone genomic loci; loss of RNF168 impairs DHX9 recruitment and R-loop resolution, leading to DSBs in BRCA1/2-mutant cells. |
Co-IP (interactome assay), in vivo ubiquitylation assay, immunofluorescence, R-loop detection (S9.6 antibody), genetic epistasis |
The Journal of clinical investigation |
Medium |
33529165
|
| 2019 |
RNF168 acts redundantly with BRCA1 to load PALB2 onto damaged DNA; loss of RNF168 negates the synthetic rescue of BRCA1 deficiency by 53BP1 deletion, placing RNF168 in a pathway parallel to BRCA1 for RAD51 loading. |
Mouse genetics (epistasis), immunofluorescence for RAD51/PALB2 foci, PARP inhibitor sensitivity assay, forced PALB2 targeting rescue |
Molecular cell |
High |
30704900
|
| 2019 |
RNF168-generated mUb-H2A recruits BARD1 through a BRCT domain ubiquitin-dependent recruitment motif (BUDR); BARD1-BRCA1 then accumulate PALB2-RAD51 at DSBs via the BRCA1 coiled-coil domain–PALB2 interaction. |
Co-IP, mouse genetics (Brca1CC mutant epistasis), immunofluorescence for PALB2/RAD51 foci |
Nature communications |
High |
34408138
|
| 2019 |
HPV E7 oncoprotein directly binds a regulatory domain of RNF168 without affecting its enzymatic activity, subverting RNF168 function at DSBs; RNF168 is required for viral genome amplification in differentiated keratinocytes. |
Co-IP (direct binding), immunofluorescence, RNAi knockdown, viral genome amplification assay |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
31501315
|
| 2019 |
PRMT5 sustains RNF168 expression; RNF168 and SMURF2 serve as stabilizer and destabilizer of H2AX, respectively, through dynamic interactions with H2AX; loss of PRMT5 (in MTAP-deficient cells) attenuates RNF168, leading to H2AX destabilization by SMURF2. |
Co-IP, in vivo ubiquitylation assay, RNAi, immunoblot |
Cell reports |
Medium |
31533041
|
| 2019 |
NMR and biochemical studies show RNF168 binds the nucleosome acidic patch and directs the E2 enzyme UBC13 toward K13/15; the structural model defines the basis for site specificity. |
NMR spectroscopy, crosslinking mass spectrometry, mutagenesis, data-driven structural modelling |
Nature communications |
High |
30988309
|
| 2014 |
RNF168 and its cognate E2 UBC13 do not stably associate in vitro or in vivo, in contrast to the RNF8-UBC13 interaction; crystal structure of the RNF168 RING domain reveals differences at the UBC13-binding interface compared to other UBC13-binding E3s; RNF8 and RNF168 RING domains are not functionally interchangeable. |
X-ray crystallography, in vitro and in vivo Co-IP, domain-swap mutagenesis |
Cell cycle |
High |
23255131
|
| 2018 |
USP14 deubiquitinase directly interacts with RNF168 via RNF168's MIU1 domain; USP14 activity negatively regulates RNF168 protein levels and RNF168-dependent H2A ubiquitination and 53BP1 recruitment; USP14 is itself a substrate of autophagy via SQSTM1. |
Co-IP, immunofluorescence, DUB activity assay, RNAi, domain mapping (MIU1) |
Autophagy |
Medium |
29995557
|
| 2020 |
RNF168 ubiquitinates H2A variants H2AZ and macroH2A1/2 at their divergent N-terminal tail lysines; the positively charged alpha1-extension helix of H2A variants and the RNF168 UMI acidic residues are essential for this reaction; a bipartite electrostatic interaction directs RNF168 orientation on the nucleosome. |
In vitro ubiquitylation assay, mutagenesis of nucleosome acidic patch and alpha1-extension helix, immunofluorescence |
Nature communications |
Medium |
32424115
|
| 2021 |
RNF8-ubiquitinated KMT5A is recruited to DSBs and binds RNF168; KMT5A promotes RNF168 catalytic activity toward H2A via its H2A acidic-patch interacting residues R188/R189, linking H4K20 monomethylation to H2A ubiquitination. |
In vitro ubiquitylation assay, Co-IP, mutagenesis (R188/R189), ChIP, immunofluorescence |
FASEB journal |
Medium |
33710666
|
| 2021 |
RNF168 is required for SLX4/FANCP recruitment to interstrand crosslink damage sites; RNF168 is epistatic with SLX4 in promoting mitomycin C tolerance; RNF168-generated K63-linked ubiquitin chains are recognized by the tandem UBZ4 domains of SLX4. |
siRNA screen with GFP-SLX4, immunofluorescence, genetic epistasis (survival assays), laser-induced ICL tracks |
Cell reports |
Medium |
34706224
|
| 2021 |
RNF168 facilitates ubiquitin signaling in RNF8/RNF168-dependent pathways that both prevent and promote DNA end resection in G0/G1 lymphocytes; combined deficiency of XLF and RNF168 leads to diminished NHEJ; in 53BP1-deficient cells, loss of RNF168 diminishes resection. |
Genetic knockouts in lymphocytes, NHEJ reporter assays, end-resection assays |
DNA repair |
Medium |
34481157
|
| 2023 |
SUMOylated RNF168 undergoes liquid-liquid phase separation (LLPS), restricting its recruitment to DNA damage sites and reducing H2A ubiquitination; SENP1 deSUMOylates RNF168, preventing LLPS and promoting RNF168 activity and NHEJ repair. |
In vitro LLPS assay, SUMOylation assay, immunofluorescence, NHEJ reporter, SENP1 knockdown/overexpression |
Cancer research |
Medium |
37350666
|
| 2023 |
HDAC6 interacts with H2A/H2A.X in unstressed cells to prevent RNF168 access; upon DSBs, RNF168 ubiquitinates HDAC6 at K116 leading to its proteasomal degradation and allowing RNF168-H2A/H2A.X interaction and subsequent H2A ubiquitination. |
Co-IP, in vivo ubiquitylation assay, immunofluorescence, mutagenesis (K116) |
Nucleic acids research |
Medium |
37503842
|
| 2024 |
Cryo-EM and NMR structures reveal the full reaction cycle of RNF168 modifying the nucleosome: RNF168 engages the nucleosome via a canonical ubiquitin-binding domain that contacts both ubiquitin and the nucleosome surface, clarifying how ubiquitin recognition drives a signal amplification loop for site-specific H2A K13/15 ubiquitination. |
Cryo-EM, NMR spectroscopy, in vitro ubiquitylation assay, mutagenesis |
Molecular cell |
High |
38242129
|
| 2024 |
Cryo-EM structures of RNF168-UbcH5c~Ub-nucleosome complexes captured during H2A K13 and K15 monoubiquitination reveal a 'helix-anchoring' mode for monomeric RNF168 on the nucleosome, distinct from the 'compass-binding' mode of dimeric E3 ligases; both K13 and K15 can be independently monoubiquitinated (adjacent dual monoubiquitination). |
Cryo-EM with chemically synthesized ubiquitin-mimetic crosslinkers, in vitro ubiquitylation assay, mutagenesis |
Nature chemical biology |
High |
39394267
|
| 2024 |
K63-linked polyubiquitin chains trigger RNF168 condensation (LLPS) in vitro and in vivo; an intrinsically disordered region (aa 460-550) is essential for RNF168 LLPS; LLPS enhances RNF168-mediated H2A.X ubiquitination, forming a positive feedback loop; LLPS deficiency delays 53BP1/BRCA1 recruitment and impairs DSB repair. |
In vitro LLPS assay with purified proteins, domain deletion mutagenesis, immunofluorescence, in vivo irradiation assays |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
38968116
|
| 2024 |
K63-linked polyubiquitylated linker histone H1.0 directly stimulates RNF168 ubiquitylation activity on nucleosomal H2A by enhancing RNF168 affinity for the chromatosome; cryo-EM of the RNF168/UbcH5c-Ub/H1.0-K63-Ub3 chromatosome complex reveals the UDM1 domain contacts K63-ubiquitin on H1.0. |
Chemical synthesis of ubiquitylated H1.0 (CAEPL strategy), in vitro ubiquitylation assay, cryo-EM |
Angewandte Chemie |
High |
39363740
|
| 2024 |
RNF168 contains a degenerate PCNA-interacting peptide (DPIP) motif that together with MIU1 mediates binding to mono-ubiquitylated PCNA at replication factories; this PCNA interaction is required for RNF168 recruitment to replication sites and support of ongoing DNA replication, but is fully dispensable for DSB signaling (53BP1 foci). |
Mutagenesis (DPIP/MIU1 double mutant), Co-IP with PCNA, immunofluorescence at replication factories, DNA fiber assay, 53BP1 foci formation assay |
Nucleic acids research |
High |
39445802
|
| 2024 |
K63-ubiquitylated H1 at different positions (K17, K46, K64, K96) stimulates RNF168 H2A ubiquitylation in a position-dependent manner; H1K17Ub2 shows the strongest RNF168 activation; di-ubiquitin binding (not monoubiquitin) drives RNF168 recruitment to DSB sites. |
Click chemistry synthesis of site-specific H1-diUb, in vitro ubiquitylation assay on nucleosome arrays, introduction of H1K17Ub2 into living cells |
Angewandte Chemie |
Medium |
39377639
|
| 2024 |
UBE2D3 E2 enzyme promotes RNF168-dependent chromatin ubiquitination and 53BP1 recruitment for NHEJ; simultaneously, UBE2D3 limits RNF168 hyperaccumulation; defective UBE2D3 leads to RNF168 hyperaccumulation that aberrantly activates PP2A phosphatase to restrict KAP1-S824 phosphorylation and NHEJ. |
RNAi/CRISPR, Co-IP, immunofluorescence, telomere NHEJ assay, phosphorylation assays |
Nature communications |
Medium |
38866770
|
| 2025 |
CDK1/2 phosphorylates RNF168 at T208, enabling PIN1 isomerase binding; PIN1 promotes SUMOylation of RNF168 at K210 (adjacent to the SPaCR motif); SUMOylation leads to p97/VCP-mediated removal of RNF168 from damaged chromatin, limiting ubiquitin signaling. |
Mutagenesis (T208, K210), Co-IP, in vivo SUMOylation assay, immunofluorescence, radiosensitivity assay |
Nature communications |
Medium |
40229270
|
| 2025 |
ZNF451 SUMO E3 ligase catalyzes SUMO2 modification of RNF168, stabilizing it and enhancing its accumulation at DSBs to increase H2A/H2AX ubiquitination; ZNF451 and RNF8 jointly regulate RNF168 recruitment in a competitive-cooperative manner. |
SUMOylation assay, Co-IP, immunofluorescence, mutagenesis, epistasis (double ZNF451/RNF8 depletion) |
Cell death and differentiation |
Medium |
40055579
|
| 2021 |
RNF168 interacts with STAT1 in the nucleus, stabilizing STAT1 protein by inhibiting its poly-ubiquitination and proteasomal degradation in esophageal cancer cells. |
Co-IP, immunoblot, RNAi knockdown |
Journal of cellular and molecular medicine |
Low |
30506884
|
| 2021 |
RNF168 directly interacts with RhoC and promotes its K48-linked ubiquitylation and proteasomal degradation in NSCLC and gastric cancer cells, suppressing cancer stem cell-like traits. |
Co-IP, in vivo ubiquitylation assay, immunoblot, overexpression/knockdown |
Environmental toxicology / Biochemical and biophysical research communications |
Low |
33865221 34873829
|
| 2018 |
RNF17 E3 ligase and its cognate E2 UBE2U function upstream of RNF168 to regulate 53BP1 foci formation at DSBs; RNF17-UBE2U constitutes a new E2-E3 module regulating the RNF168 pathway. |
RNAi-based E2 screen, immunofluorescence for 53BP1 foci, Co-IP for UBE2U-RNF17 interaction |
The Journal of biological chemistry |
Low |
27903633
|
| 2014 |
BCL10 is recruited to DSBs in an ATM- and RNF8-dependent manner; ATM-dependent BCL10 phosphorylation promotes BCL10-UBC13 interaction; RNF8-mediated BCL10 ubiquitination enhances BCL10 and UBC13 binding to RNF168, facilitating RNF168-dependent H2AX monoubiquitination. |
Co-IP, in vivo ubiquitylation assay, immunofluorescence, ATM inhibitor experiments |
Cell cycle |
Low |
24732096
|
| 2014 |
RNF168 and SET8 methyltransferase form stable complexes in vivo; SET8 recruitment to DSBs is abolished by RNF8 or RNF168 knockdown or by proteasome inhibition that depletes free ubiquitin, placing SET8 downstream of RNF168 in the DSB pathway. |
Co-IP, RNAi epistasis, proteasome inhibitor, immunofluorescence |
Cell cycle |
Low |
31760894
|
| 2024 |
RNF168 promotes ubiquitination and degradation of ANXA7, suppressing autophagy and inducing NLRP3 inflammasome-mediated pyroptosis; ELK1 transcription factor regulates RNF168 expression in this colitis context. |
Co-IP, ubiquitination assay, siRNA knockdown, in vivo mouse model |
Apoptosis |
Low |
41518435
|